These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 579055)

  • 21. Disposition kinetics of quinidine.
    Ueda CT; Hirschfeld DS; Scheinman MM; Rowland M; Williamson BJ; Dzindzio BS
    Clin Pharmacol Ther; 1976 Jan; 19(1):30-6. PubMed ID: 1245091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of quinidine and three of its metabolites in man.
    Rakhit A; Holford NH; Guentert TW; Maloney K; Riegelman S
    J Pharmacokinet Biopharm; 1984 Feb; 12(1):1-21. PubMed ID: 6747817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digitoxin-quinidine interaction: pharmacokinetic evaluation.
    Fenster PE; Powell JR; Graves PE; Conrad KA; Hager WD; Goldman S; Marcus FI
    Ann Intern Med; 1980 Nov; 93(5):698-701. PubMed ID: 7212478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concentration-time effects of quinidine disposition kinetics in rhesus monkeys.
    Ueda CT; Ballard B; Rowland M
    J Pharmacol Exp Ther; 1977 Mar; 200(3):459-68. PubMed ID: 403278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of increased plasma quinidine concentration in rats with glycerol- and cisplatin-induced acute renal failure.
    Izuwa Y; Kusaba J; Horiuchi M; Aiba T; Kawasaki H; Kurosaki Y
    Drug Metab Pharmacokinet; 2009; 24(5):451-7. PubMed ID: 19881257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinidine-digoxin interaction: are the pharmacokinetics of both drugs altered?
    Rameis H
    Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):145-53. PubMed ID: 3997300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic studies of quinidine in patients with arrhythmias.
    Conrad KA; Molk BL; Chidsey CA
    Circulation; 1977 Jan; 55(1):1-7. PubMed ID: 830196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Development of serum and tissue concentrations of quinidine following intravenous injection].
    Armand J; Evreux JC; Badinand A; Faucon G
    Med Exp Int J Exp Med; 1969; 19(1):22-7. PubMed ID: 5395539
    [No Abstract]   [Full Text] [Related]  

  • 29. Lack of effect of cimetidine on the metabolism of quinidine: effect on renal clearance.
    Hardy BG; Schentag JJ
    Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):388-91. PubMed ID: 3220613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of quinidine sulfate in dairy cattle.
    Takemura N; Fujii T; Koyama H; Sako T; Suzuki K; Uchino T; Motoyoshi S
    Nihon Juigaku Zasshi; 1989 Jun; 51(3):515-20. PubMed ID: 2761143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of digoxin in patients subjected to the quinidine-digoxin interaction.
    Schenck-Gustafsson K; Dahlqvist R
    Br J Clin Pharmacol; 1981 Feb; 11(2):181-6. PubMed ID: 7213521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetics and dynamics of quinidine-N-oxide in healthy subjects.
    Ha HR; Vozeh S; Uematsu T; Guentert TW; Follath F
    Clin Pharmacol Ther; 1987 Sep; 42(3):341-5. PubMed ID: 3621790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of quinidine on digoxin distribution and elimination in guinea pigs.
    Sato J; Sawada Y; Iga T; Hanano M
    J Pharm Sci; 1983 Oct; 72(10):1137-41. PubMed ID: 6644558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of the ORM1 phenotypes on serum unbound concentration and protein binding of quinidine.
    Li JH; Xu JQ; Cao XM; Ni L; Li Y; Zhuang YY; Gong JB
    Clin Chim Acta; 2002 Mar; 317(1-2):85-92. PubMed ID: 11814462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quinidine pharmacokinetics in man: choice of a disposition model and absolute bioavailability studies.
    Guentert TW; Holford NH; Coates PE; Upton RA; Riegelman S
    J Pharmacokinet Biopharm; 1979 Aug; 7(4):315-30. PubMed ID: 512840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of nonlinear tissue distribution of quinidine in rats by physiologically based pharmacokinetics.
    Harashima H; Sawada Y; Sugiyama Y; Iga T; Hanano M
    J Pharmacokinet Biopharm; 1985 Aug; 13(4):425-40. PubMed ID: 4087170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacokinetics and organ distribution of ajmaline and quindine in the mouse.
    Iven H
    Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):43-50. PubMed ID: 882146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical oral doses of dexamethasone decreases intrinsic clearance of quinidine, a cytochrome P450 3A substrate in dogs.
    Zhang K; Kohno S; Kuroha M; Kokue E; Shimoda M
    J Vet Med Sci; 2006 Sep; 68(9):903-7. PubMed ID: 17019057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of high (3S)-3-hydroxyquinidine/quinidine ratios in serum, and clearance of quinidine in cardiac patients with age.
    Drayer DE; Hughes M; Lorenzo B; Reidenberg MM
    Clin Pharmacol Ther; 1980 Jan; 27(1):72-5. PubMed ID: 7351119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of congestive heart failure on quinidine pharmacokinetics.
    Crouthamel WG
    Am Heart J; 1975 Sep; 90(3):335-9. PubMed ID: 1163425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.